Why is AbbVie Inc. stock up today?
July 18, 2026
AbbVie Inc.
ABBV · NYQ · USD
vs. prev. close $254.39
Last updated Jul 17, 2026 20:02
Intraday Chart — 5-min intervals
ABBV · less than a minute ago
AbbVie Inc. edges higher 0.04% — Trefis reports
AbbVie Inc. (ABBV) is holding steady with a slight gain, at $254. 49 — up 0. 04% from yesterday's close of $254. 39. Today's move appears driven by recent headlines, including "The Real Question Buried Inside Merck Stock's Premium Price" and "AbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe". News sentiment around ABBV is leaning positive.
The broader market is under pressure (S&P 500: -1. 0%, Nasdaq: -1. 4%, Dow Jones: -0. 8%, Shanghai: -3. 0%, Hang Seng: -1. 8%). Past performance does not guarantee future results.
Key Factors
Auto-generated analysis · Not financial advice
The Real Question Buried Inside Merck Stock's Premium Price
Trefis·about 7 hours agoneutralAbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe
Simply Wall St.·about 10 hours agoneutralVYM’s $94.6 Billion Portfolio Beats Treasury Yields with Dividend Kings Leading the Way
24/7 Wall St.·about 12 hours agopositive
The Argus Min Vol Model Portfolio
Argus Research·about 15 hours agoneutralAbbVie's Allergan Aesthetics Says Boey Wrinkle Treatment Wins EU Approval
MT Newswires·about 16 hours agoneutralAllergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE), for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
PR Newswire·about 17 hours agoneutralWhy Healthcare Stocks Look Like a Haven in This Market
Barrons.com·1 day agoneutralWhy Abbott Stock Is Having Its Best Day in 24 Years
Barrons.com·1 day agoneutral
S&P 500
-1.01%
Nasdaq
-1.40%
Dow Jones
-0.77%
Shanghai
-3.05%
Hang Seng
-1.78%
Nikkei 225
-4.03%
FTSE 100
+0.27%
Nifty 50
+1.09%
DAX
-0.34%
OMX Stockholm
-0.08%
Search another stock